Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global at-home drug of abuse (DOA) testing market 360° synopsis, 2018 – 2032
2.2 Regional trends
2.3 Type trends
2.4 Sample type trends
Chapter 3 At-home Drug of Abuse (DOA) Testing Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Rise in the production of illicit drugs
3.5.1.2 Growing government initiatives to curb drug abuse
3.5.1.3 Surge in access to drugs
3.5.1.4 Technological advancements and product portfolio expansion
3.5.2 Industry pitfalls & challenges
3.5.2.1 Inability of testing products to detect small amounts of special drugs
3.5.2.2 Lack of awareness regarding drug testing
3.6 Growth potential analysis
3.6.1 By type
3.6.2 By sample type
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Competitive analysis of major market players, 2022
4.2.1 Abbott Laboratories
4.2.2 Dragerwerk AG & Co. KGaA
4.2.3 F. Hoffmann-La Roche AG
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 At-home Drug of Abuse (DOA) Testing Market Estimates and Forecast, By Type (Revenue and Volume)
5.1 Key trends, by type
5.2 Test cups
5.3 Test strips
5.4 Others
Chapter 6 At-home Drug of Abuse (DOA) Testing Market Estimates and Forecast, By Sample Type (Revenue)
6.1 Key trends, by sample type
6.2 Saliva
6.3 Urine
6.4 Blood
6.5 Others
Chapter 7 At-home Drug of Abuse (DOA) Testing Market Estimates and Forecast, By Region (Revenue and Volume)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Switzerland
7.3.7 The Netherlands
7.3.8 Denmark
7.3.9 Poland
7.3.10 Sweden
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 New Zealand
7.4.7 Thailand
7.4.8 Vietnam
7.4.9 Indonesia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Colombia
7.5.5 Chile
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Turkey
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.2 Dragerwerk AG & Co. KGaA
8.3 Assure Tech.(Hangzhou) Co., LTD
8.4 Atlas Medical GmbH
8.5 Confirm BioSciences
8.6 F. Hoffmann-La Roche AG
8.7 Siemens Healthineers AG
8.8 Thermo Fisher Scientific, Inc.
8.9 Bio-Rad Laboratories, Inc.
8.10 bioMérieux SA
8.11 Psychemedics Corporation
8.12 OraSure Technologies, Inc.
